龙芯中科(688047) - 2022 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2022 was ¥136,147,636.43, a decrease of 35.73% compared to the same period last year[4] - The net profit attributable to shareholders for Q3 2022 was -¥15,715,245.44, representing a decline of 154.55% year-on-year[4] - Total operating revenue for the first three quarters of 2022 was ¥483,762,764.25, a decrease of 37.5% compared to ¥774,694,278.41 in the same period of 2021[20] - Net profit for the first three quarters of 2022 was ¥73,048,006.35, a decline of 38.5% from ¥118,975,137.54 in the same period of 2021[21] - Basic and diluted earnings per share for the first three quarters of 2022 were both ¥0.20, down from ¥0.33 in the same period of 2021[23] Research and Development - The total R&D investment in Q3 2022 was ¥101,709,871.23, an increase of 35.51% compared to the same period last year[5] - R&D investment accounted for 74.71% of operating revenue in Q3 2022, up 39.28 percentage points year-on-year[5] - Research and development expenses for the first three quarters of 2022 were ¥211,721,945.09, an increase of 14.5% from ¥185,099,739.43 in the previous year[20] - The company continues to increase R&D investment, which is expected to impact future profitability positively despite current losses[8] - The company has not provided specific guidance for future performance but emphasizes ongoing investment in research and development[14] Assets and Liabilities - The total assets at the end of Q3 2022 were ¥4,367,402,474.06, an increase of 119.52% compared to the end of the previous year[5] - The equity attributable to shareholders at the end of Q3 2022 was ¥3,903,175,238.43, up 180.34% year-on-year[5] - The company's current assets totaled CNY 3.70 billion, up from CNY 1.36 billion in the previous year, indicating a year-over-year increase of 171.5%[15] - The company's total liabilities decreased to CNY 464.23 million from CNY 597.20 million, a reduction of 22.3%[17] - The equity attributable to shareholders increased significantly to CNY 3.90 billion from CNY 1.39 billion, representing a growth of 180.5%[17] Cash Flow - The net cash flow from operating activities for the year-to-date was -¥448,225,595.46, indicating a significant cash outflow[5] - Cash inflow from operating activities was ¥649,833,167.61, a decrease of 29.7% compared to ¥924,018,717.84 in the previous year[24] - Cash outflow from operating activities increased to ¥1,098,058,763.07, compared to ¥969,440,642.35 in the same period of 2021[24] - Net cash flow from operating activities was -$448.23 million, compared to -$45.42 million in the previous period[26] - The net increase in cash and cash equivalents was $212.85 million, contrasting with a decrease of $240.62 million in the previous period[26] Other Financial Metrics - The basic earnings per share for Q3 2022 was -¥0.04, a decrease of 150.00% compared to the same period last year[5] - The diluted earnings per share for Q3 2022 was also -¥0.04, reflecting the same decline as basic earnings per share[5] - Other income for the first three quarters of 2022 was ¥170,299,338.99, significantly up from ¥27,339,649.42 in the same period of 2021[20] - Tax expenses for the first three quarters of 2022 were ¥2,809,115.75, down 37.2% from ¥4,484,542.07 in the previous year[20] - The company reported a credit impairment loss of ¥-15,033,608.37 for the first three quarters of 2022, compared to ¥-2,108,880.45 in the same period of 2021[20]